Literature DB >> 32024441

Elevated levels of IL-8 in fatal leptospirosis.

Wan Shahriman Yushdie Wan Yusoff1,2, Maha Abdullah3, Zamberi Sekawi2, Fairuz Amran4, Muhammad Yazli Yuhana5, Niazlin Mohd Taib2, Anim Md Shah6, Syafinaz Amin Nordin2.   

Abstract

Leptospirosis causes a wide range of clinical outcomes, including organ failure and death. Early treatment significantly increases the chances of cure. Interleukin-8 (IL-8) is a chemoattractant cytokine for neutrophil and is associated with multiple organ failure. Research has indicated IL-8 to be raised in severe and fatal cases of leptospirosis, but its suitability as a prognostic biomarker has yet to be confirmed. This study aimed to evaluate the significance of IL-8 with the clinical outcomes of leptospirosis patients. Plasma IL-8 was measured in fifty-two samples from hospitalized patients and nineteen healthy controls. The comparisons were made between mild, severe-survived and fatal groups identified by clinical or laboratory findings. IL-8 was significantly higher in fatal (p = 0.01) compared to mild cases. IL-8 was also significantly higher in fatal (p = 0.02) when compared to survived cases of leptospirosis. IL-8 levels in the plasma of fatal leptospirosis cases were significantly elevated compared to survived cases and may serve as a potential prognostic biomarker in determining the possible outcome of leptospirosis patients.

Entities:  

Keywords:  IL-8; clinical Outcomes; cytokines; leptospirosis; malaysia

Mesh:

Substances:

Year:  2020        PMID: 32024441      PMCID: PMC7170329          DOI: 10.1080/20477724.2020.1724356

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  29 in total

1.  Cytokine profile of patients with leptospirosis in Sabah, Malaysia.

Authors:  B J Mohd Iskandar; T William; J Daisy Vanitha
Journal:  Med J Malaysia       Date:  2018-04

2.  Cytokine levels as biomarkers for leptospirosis patients.

Authors:  C Chirathaworn; Y Supputtamongkol; S Lertmaharit; Y Poovorawan
Journal:  Cytokine       Date:  2016-06-10       Impact factor: 3.861

Review 3.  Leptospirosis--an overview.

Authors:  T K Dutta; M Christopher
Journal:  J Assoc Physicians India       Date:  2005-06

4.  Severity markers in severe leptospirosis: a cohort study.

Authors:  M Mikulski; P Boisier; F Lacassin; M-E Soupé-Gilbert; C Mauron; L Bruyere-Ostells; D Bonte; Y Barguil; A-C Gourinat; M Matsui; F Vernel-Pauillac; C Goarant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

5.  Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-κB signaling pathways.

Authors:  Huan Wang; Yifei Wu; David M Ojcius; X Frank Yang; Chenglin Zhang; Shibiao Ding; Xu'ai Lin; Jie Yan
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 6.  Global Morbidity and Mortality of Leptospirosis: A Systematic Review.

Authors:  Federico Costa; José E Hagan; Juan Calcagno; Michael Kane; Paul Torgerson; Martha S Martinez-Silveira; Claudia Stein; Bernadette Abela-Ridder; Albert I Ko
Journal:  PLoS Negl Trop Dis       Date:  2015-09-17

Review 7.  Retrospective Study of Leptospirosis in Malaysia.

Authors:  Bashiru Garba; Abdul Rani Bahaman; Siti Khairani-Bejo; Zunita Zakaria; Abdul Rahim Mutalib
Journal:  Ecohealth       Date:  2017-04-12       Impact factor: 3.184

8.  Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.

Authors:  Fernando A Bozza; Jorge I Salluh; André M Japiassu; Marcio Soares; Edson F Assis; Rachel N Gomes; Marcelo T Bozza; Hugo C Castro-Faria-Neto; Patrícia T Bozza
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.

Authors:  Jiri F P Wagenaar; M Hussein Gasem; Marga G A Goris; Mariska Leeflang; Rudy A Hartskeerl; Tom van der Poll; Cornelis van 't Veer; Eric C M van Gorp
Journal:  PLoS Negl Trop Dis       Date:  2009-06-02

10.  Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil.

Authors:  Edilane L Gouveia; John Metcalfe; Ana Luiza F de Carvalho; Talita S F Aires; José Caetano Villasboas-Bisneto; Adriano Queirroz; Andréia C Santos; Kátia Salgado; Mitermayer G Reis; Albert I Ko
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.